Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evan T Hall

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal for Immunotherapy of Cancer|December 25, 2025
Real-world outcomes of talimogene laherparepvec as salvage therapy for advanced melanomaMelissa M Yamada, Smitha Chandrasekhar, Ted A Gooley, et al.
Future Oncology (London, England)|January 5, 2021
Predictive lifestyle markers for efficacy of cancer immune checkpoint inhibitors: a commentaryArthur Sillah, Scott S Tykodi, Evan T Hall, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 16, 2022
Associating sleep problems with advanced cancer diagnosis, and immune checkpoint treatment outcomes: a pilot studyArthur Sillah, Ulrike Peters, Nathaniel F Watson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2021
Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline UpdateJennifer J Griggs, Kari Bohlke, Edward P Balaban, et al.
Future Oncology (London, England)|September 11, 2024
Focal therapy for oligometastatic and oligoprogressive renal cell carcinoma: a narrative reviewAugust C Anderson, Joel Ho, Evan T Hall, et al.
Cancer Cell|April 12, 2022
Neoantigen-specific CD4<sup>+</sup> T cells in human melanoma have diverse differentiation states and correlate with CD8<sup>+</sup> T cell, macrophage, and B cell functionJoshua R Veatch, Sylvia M Lee, Carolyn Shasha, et al.
Journal of the American Academy of Dermatology|October 12, 2025
Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient managementTomoko Akaike, Manisha Thakuria, Ann W Silk, et al.
Urologic Oncology|November 28, 2022
A multicenter study assessing survival in patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitor therapy with and without cytoreductive nephrectomyEvan E Gross, Mingjia Li, Ming Yin, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal for Immunotherapy of Cancer|December 25, 2025
Real-world outcomes of talimogene laherparepvec as salvage therapy for advanced melanomaMelissa M Yamada, Smitha Chandrasekhar, Ted A Gooley, et al.
Future Oncology (London, England)|January 5, 2021
Predictive lifestyle markers for efficacy of cancer immune checkpoint inhibitors: a commentaryArthur Sillah, Scott S Tykodi, Evan T Hall, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 16, 2022
Associating sleep problems with advanced cancer diagnosis, and immune checkpoint treatment outcomes: a pilot studyArthur Sillah, Ulrike Peters, Nathaniel F Watson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2021
Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline UpdateJennifer J Griggs, Kari Bohlke, Edward P Balaban, et al.
Future Oncology (London, England)|September 11, 2024
Focal therapy for oligometastatic and oligoprogressive renal cell carcinoma: a narrative reviewAugust C Anderson, Joel Ho, Evan T Hall, et al.
Cancer Cell|April 12, 2022
Neoantigen-specific CD4<sup>+</sup> T cells in human melanoma have diverse differentiation states and correlate with CD8<sup>+</sup> T cell, macrophage, and B cell functionJoshua R Veatch, Sylvia M Lee, Carolyn Shasha, et al.
Journal of the American Academy of Dermatology|October 12, 2025
Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient managementTomoko Akaike, Manisha Thakuria, Ann W Silk, et al.
Urologic Oncology|November 28, 2022
A multicenter study assessing survival in patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitor therapy with and without cytoreductive nephrectomyEvan E Gross, Mingjia Li, Ming Yin, et al.
Pageof 3